{"id": "chatcmpl-8JZmENnzHaEAOvo0AHp4DfVRDx2ws", "object": "chat.completion", "created": 1699676450, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. The primary efficacy endpoint is the mean sitDBP change from baseline to Week 8.\n2. This endpoint was compared between different groups.\n3. One group was given the combination of CKD-828 2.5/40 mg and CKD-828 2.5/80 mg.\n4. Another group was given S-amlodipine monotherapy.\n5. The comparison was made between the combination group and the S-amlodipine monotherapy group."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 86, "completion_tokens": 100, "total_tokens": 186}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: The primary efficacy endpoint, mean sitDBP change from baseline to Week 8, was compared between the combination (CKD-828 2.5/40 mg and CKD-828 2.5/80 mg) and S-amlodipine monotherapy groups.\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}